Table 2.
Characteristic | mRNA Positive (n = 27) |
DNA Positive, mRNA Negative (n = 112) |
HBoV Negative (n = 1157) |
---|---|---|---|
Age, y | 1.3 (0.8–1.5) | 2.0 (1.0–5.8) | 2.6 (1.0–6.8) |
Female sex | 11 (41) | 56 (50) | 532 (46) |
Underlying conditiona | 11 (41) | 29 (26) | 371 (32) |
Symptom onset to specimen collection, d | 4 (3–5) | 5 (3–8) | 5 (3–8) |
Pathogen codetectionb | |||
Virus | 14 (52) | 84 (75) | 827 (71) |
Bacteria | 3 (11) | 23 (21) | 183 (16) |
Data are median value (interquartile range) or no. (%) of participants.
aSee Table 1 and for definition and additional information [27].
bNumbers only reflect detection of viruses and bacteria per the EPIC study protocol and exclude HBoV.